Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT01657955 · UNKNOWN
Trial details
- NCT number
- NCT01657955
- Sponsor
- Shandong Lanjin Pharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-10-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.